Company profile

Beijing Infervision Healthcare Medical Technology Co., Ltd.

Beijing Infervision Healthcare Medical Technology Co., Ltd. has 2 AI-enabled medical devices on the FDA list. The first decision was on September 15, 2025 and the most recent on March 13, 2026 (InferCare RECIST). Its most common review panel is Radiology (2 devices).

2AI devices
2025First decision
2026Latest decision
1Specialties

Related guides

Top radiology devices

Timeline

  1. InferCare RECIST · Radiology · QIH
  2. InferOperate Suite · Radiology · QIH